176 related articles for article (PubMed ID: 37507044)
1. Targeting anticancer immunity in oral cancer: Drugs, products, and nanoparticles.
Qin L; Wu J
Environ Res; 2023 Dec; 239(Pt 1):116751. PubMed ID: 37507044
[TBL] [Abstract][Full Text] [Related]
2. Targeting oral tumor microenvironment for effective therapy.
Budi HS; Farhood B
Cancer Cell Int; 2023 May; 23(1):101. PubMed ID: 37221555
[TBL] [Abstract][Full Text] [Related]
3. Exploiting the immune system in hepatic tumor targeting: Unleashing the potential of drugs, natural products, and nanoparticles.
Hsu CY; Mustafa MA; Kumar A; Pramanik A; Sharma R; Mohammed F; Jawad IA; Mohammed IJ; Alshahrani MY; Ali Khalil NAM; Shnishil AT; Abosaoda MK
Pathol Res Pract; 2024 Apr; 256():155266. PubMed ID: 38554489
[TBL] [Abstract][Full Text] [Related]
4. Boosting Anti-tumour Immunity Using Adjuvant Apigenin.
Huang J; Chen X; Chang Z; Xiao C; Najafi M
Anticancer Agents Med Chem; 2023; 23(3):266-277. PubMed ID: 35616683
[TBL] [Abstract][Full Text] [Related]
5. Tumor microenvironment remodeling in oral cancer: Application of plant derived-natural products and nanomaterials.
Budi HS; Farhood B
Environ Res; 2023 Sep; 233():116432. PubMed ID: 37331557
[TBL] [Abstract][Full Text] [Related]
6. Tumor-associated Macrophages (TAMs) in Cancer Resistance; Modulation by Natural Products.
Lafta HA; AbdulHussein AH; Al-Shalah SAJ; Alnassar YS; Mohammed NM; Akram SM; Qasim MT; Najafi M
Curr Top Med Chem; 2023; 23(12):1104-1122. PubMed ID: 36722486
[TBL] [Abstract][Full Text] [Related]
7. Boosting immune system against cancer by resveratrol.
Chen L; Musa AE
Phytother Res; 2021 Oct; 35(10):5514-5526. PubMed ID: 34101276
[TBL] [Abstract][Full Text] [Related]
8. Improving function of cytotoxic T-lymphocytes by transforming growth factor-β inhibitor in oral squamous cell carcinoma.
Kondo Y; Suzuki S; Takahara T; Ono S; Goto M; Miyabe S; Sugita Y; Ogawa T; Ito H; Satou A; Tsuzuki T; Yoshikawa K; Ueda R; Nagao T
Cancer Sci; 2021 Oct; 112(10):4037-4049. PubMed ID: 34309966
[TBL] [Abstract][Full Text] [Related]
9. Targeting of the tumor immune microenvironment by metformin.
Wu Z; Zhang C; Najafi M
J Cell Commun Signal; 2022 Sep; 16(3):333-348. PubMed ID: 34611852
[TBL] [Abstract][Full Text] [Related]
10. Boosting immune responses in lung tumor immune microenvironment: A comprehensive review of strategies and adjuvants.
Gao F; You X; Yang L; Zou X; Sui B
Int Rev Immunol; 2024 Mar; ():1-29. PubMed ID: 38525925
[TBL] [Abstract][Full Text] [Related]
11. CD8
Farhood B; Najafi M; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
[TBL] [Abstract][Full Text] [Related]
12. Targeting of the tumor microenvironment by curcumin.
Fu X; He Y; Li M; Huang Z; Najafi M
Biofactors; 2021 Nov; 47(6):914-932. PubMed ID: 34375483
[TBL] [Abstract][Full Text] [Related]
13. The interactions of docetaxel with tumor microenvironment.
Gupta R; Kadhim MM; Turki Jalil A; Qasim Alasheqi M; Alsaikhan F; Khalimovna Mukhamedova N; Alexis Ramírez-Coronel A; Hassan Jawhar Z; Ramaiah P; Najafi M
Int Immunopharmacol; 2023 Jun; 119():110214. PubMed ID: 37126985
[TBL] [Abstract][Full Text] [Related]
14. Novel mucoadhesive celecoxib-loaded cubosomal sponges: Anticancer potential and regulation of myeloid-derived suppressor cells in oral squamous cell carcinoma.
Mabrouk AA; El-Mezayen NS; Tadros MI; El-Gazayerly ON; El-Refaie WM
Eur J Pharm Biopharm; 2023 Jan; 182():62-80. PubMed ID: 36513316
[TBL] [Abstract][Full Text] [Related]
15. Polymeric indoximod based prodrug nanoparticles with doxorubicin entrapment for inducing immunogenic cell death and improving the immunotherapy of breast cancer.
Zang X; Song J; Yi X; Piyu J
J Mater Chem B; 2022 Mar; 10(12):2019-2027. PubMed ID: 35254372
[TBL] [Abstract][Full Text] [Related]
16. Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy.
Gaggero S; Witt K; Carlsten M; Mitra S
Front Immunol; 2020; 11():621225. PubMed ID: 33584718
[TBL] [Abstract][Full Text] [Related]
17. Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy.
Sun L; Clavijo PE; Robbins Y; Patel P; Friedman J; Greene S; Das R; Silvin C; Van Waes C; Horn LA; Schlom J; Palena C; Maeda D; Zebala J; Allen CT
JCI Insight; 2019 Apr; 4(7):. PubMed ID: 30944253
[TBL] [Abstract][Full Text] [Related]
18. Breaking Tumor Immunosuppressive Network by Regulating Multiple Nodes with Triadic Drug Delivery Nanoparticles.
Yan W; Li Y; Zou Y; Zhu R; Wu T; Sun X; Yuan W; Lang T; Yin Q; Li Y
ACS Nano; 2023 Sep; 17(18):17826-17844. PubMed ID: 37690028
[TBL] [Abstract][Full Text] [Related]
19. Regorafenib enhances antitumor immune efficacy of anti-PD-L1 immunotherapy on oral squamous cell carcinoma.
Chiang IT; Lee YH; Tan ZL; Hsu FT; Tu HF
Biomed Pharmacother; 2022 Mar; 147():112661. PubMed ID: 35092865
[TBL] [Abstract][Full Text] [Related]
20. Targeting the prostate tumor microenvironment by plant-derived natural products.
Wu J; Ji H; Li T; Guo H; Xu H; Zhu J; Tian J; Gao M; Wang X; Zhang A
Cell Signal; 2024 Mar; 115():111011. PubMed ID: 38104704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
